GHK-CU 100mg
Glycyl-L-Histidyl-L-Lysine Copper (GHK-Cu)
Retatrutide
Strength
10 mg
Presentation
1 Vial
Total Content
10 mg
Base
N/A
Origin
Made in USA
10 mg PER ml
1 VIAL
N/A BASED
HIGH QUALITY
FOR RESEARCH USE ONLY
SPECIFICATIONS
Company:
BioGen Pharma
Active Half-life:
e.g. 5-6 days
Group:
Peptide Injection
Subgroup:
GLP-1 / GIP / Glucagon Receptor Agonist
Dosage:
10 mg
Application:
Subcutaneous Injection
Product pack:
1 Vial
Content:
10mg Retatrutide (Lyophilized Powder)
Oil-based:
No
Retains water:
No
Aromatization:
No
DESCRIPTION
Retatrutide is a next-generation peptide targeting GLP-1, GIP, and Glucagon receptors, designed to support weight management and metabolic health.
Retatrutide is a next-generation peptide that acts on three key hormone receptors: GLP-1, GIP, and Glucagon. It is designed to support significant weight management and metabolic health improvements.
Retatrutide works by targeting GLP-1, GIP, and Glucagon receptors to regulate appetite, increase energy expenditure, and improve insulin sensitivity. This helps reduce body weight, control blood sugar levels, and enhance overall metabolic function.
Retatrutide works by targeting GLP-1, GIP, and Glucagon receptors to regulate appetite, increase energy expenditure, and improve insulin sensitivity. This helps reduce body weight, control blood sugar levels, and enhance overall metabolic function.
- Next-generation peptide acting on GLP-1, GIP, and Glucagon receptors
- Supports significant weight management and metabolic health
- Regulates appetite and increases energy expenditure
- Improves insulin sensitivity and helps control blood sugar
- High Quality Peptide - Lab Tested
- Research Use Only - Advanced Formula
STORAGE & SAFETY
Store lyophilized powder in the refrigerator (2°C – 8°C). Protect from light and moisture. Do not freeze. Keep out of reach of children. FOR RESEARCH USE ONLY – NOT FOR HUMAN CONSUMPTION.
Related Injectables